U.S. FDA advises manufacturers to add a spike protein component of the Omicron subvariants BA.4 and BA.5 to their prototype vaccines for fall boosters.
New guidance from the the College of Pharmacists of Manitoba includes a decision tree for pharmacists to help parents navigate their formula choices safely.